Collagen-Induced Arthritis Mouse Model
- PMID: 34890495
- DOI: 10.1002/cpz1.313
Collagen-Induced Arthritis Mouse Model
Erratum in
-
Group Correction Statement (Human or Animal Subject Note).Curr Protoc. 2022 Aug;2(8):e554. doi: 10.1002/cpz1.554. Curr Protoc. 2022. PMID: 36005901 No abstract available.
Abstract
The collagen-induced arthritis mouse model is a widely studied autoimmune model of rheumatoid arthritis. In this model, autoimmune arthritis is induced by immunization of genetically susceptible strains of mice with type II collagen emulsified in complete Freund's adjuvant. This article describes the steps necessary for the acquisition, handling, and preparation of CII, in addition to the selection of mouse strains, proper immunization technique, and methods for evaluation of the incidence and severity of the autoimmune arthritis. In this model, the first signs of arthritis appear approximately 21 to 28 days after immunization. The protocols in this article should provide the investigator with all the necessary information required to reproducibly induce a high incidence of CIA in genetically susceptible strains of mice, and to critically evaluate the pathology of the disease. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Basic Protocol: Induction of collagen-induced arthritis Support Protocol 1: Purification of type II collagen Support Protocol 2: Purification of type II collagen α1(II) chains Support Protocol 3: Assessment of arthritis incidence and severity Support Protocol 4: Measurement of CII specific antibody by indirect ELISA Support Protocol 5: Coupling CII to magnetic beads Support Protocol 6: Measuring CII-specific antibody by magnetic-bead based ELISA Support Protocol 7: Measurement of T cell responses to CII in CIA.
Keywords: arthritis; autoimmunity; collagen; model; mouse.
Published 2021. This article is a U.S. Government work and is in the public domain in the USA.
References
Literature Cited
-
- Amirahmadi, S. F., Whittingham, S., Crombie, D. E., Nandakumar, K. S., Holmdahl, R., Mackay, I. R., … Rowley, M. J. (2005). Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cells. Arthritis and Rheumatism, 52(6), 1897-1906. doi: 10.1002/art.21097.
-
- Andersson, E. C., Hansen, B. E., Jacobsen, H., Madsen, L. S., Andersen, C. B., Engberg, J., … Fugger, L. (1998). Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Proceedings of the National Academy of Sciences of the United States of America, 95(13), 7574-7579.
-
- Andrew, S. M., & Titus, J. A. (2001). Purification of immunoglobulin G. Current Protocols in Immunology, 21, 2.7.1-2.7.12. doi: 10.1002/0471142735.im0207s21.
-
- Andrew, S. M., Titus, J. A., & Zumstein, L. (2001). Dialysis and concentration of protein solutions. Current Protocols in Immunology, 21, A.3H.1-A.3H.5. doi: 10.1002/0471142735.ima03hs21.
-
- Bajtner, E., Nandakumar, K. S., Engstrom, A., & Holmdahl, R. (2005). Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Research & Therapy, 7(5), R1148-1157. doi: 10.1186/ar1800.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
